Last update 01 Nov 2024

STADAPHARM GmbH

Subsidiary Company|
Germany
|
www.cellpharm.com

Overview

Tags

Nervous System Diseases
Endocrinology and Metabolic Disease
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
DNAJB3 x NF-κB1

Related

1
Drugs associated with STADAPHARM GmbH
Lipoic acid
Target
DNAJB3 x NF-κB
Mechanism
DNAJB3 modulators [+1]
Active Org.
Bukwang Pharmaceutical Co., Ltd.Bukwang Pharmaceutical Co., Ltd. [+2]
Originator Org.-
Active Indication
Diabetic Neuropathies [+2]
Inactive Indication
Acne Vulgaris [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
DE
First Approval Date01 Jan 1966
2
Clinical Trials associated with STADAPHARM GmbH
NCT05579379 / Not yet recruitingNot ApplicableIIT
DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Support Dopaminergic Desensitization in Parkinson's Disease
DRKS00013497 / CompletedNot Applicable
Study on the incidence of genetic polymorphism in patients with major depression who are treated unsatisfactory with antidepressants - GENADET
100 Clinical Results associated with STADAPHARM GmbH
Login to view more data
0 Patents (Medical) associated with STADAPHARM GmbH
Login to view more data
100 Deals associated with STADAPHARM GmbH
Login to view more data
100 Translational Medicine associated with STADAPHARM GmbH
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Lipoic acid
 ( DNAJB3 x NF-κB )		Diabetic Neuropathies
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free